Menu
English
Українська
Home
About edition
New issue
Archive
Author
Information for authors
Publications requirements
English
Українська
Ключевое слово : chronic lymphocytic leukemia
CONCERNING THE LATENT INFECTION PROGRAMS OF EPSTEIN-BARR VIRUS IN B-CELLS OF CHRONIC LYMPHOCYTIC LEUKEMIA
№26 4 2024
11
EVALUATION OF CD38 ANTIGEN EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA: THE EXPERIENCE OF CLINICAL IMMUNOLOGY DEPARTMENT, NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE, NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE
№25 3 2023
30
THE EFFECT OF ACTIVATION OF TOLL-LIKE RECEPTORS ON THE CD150 EXPRESSION LEVEL IN MALIGNANT B-LYMPHOCYTES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
Authors:Shcherbina V.M. Gordiienko I.M.
№24 2 2022
14
APPLICATION OF BIOINFORMATICS FOR ANALYSIS OF CELLULAR SIGNAL TRANSDUCTION PATHWAYS
Authors:Kovalevska L.M. Matvieieva A.S. Kashuba E.V.
№22 3-4 2020
20
RS6449182 CD38 GENE POLYMORPHISM AND THE RISK OF CHRONIC LYMPHOCYTIC LEUKEMIA DEVELOPMENT
Authors:Bilous N.I. Chumak A.A. Martina Z.V. Filonenko I.A.
№13 4 2011
13
INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
2019-04-04
7
CAMPAT IN THE THERAPY OF CHRONIC LYMPHOCITIC LEUKEMIA: ACHIEVEMENTS AND PERSPECTIVES
2019-04-04
2
INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
2019-04-04
4
CAMPAT IN THE THERAPY OF CHRONIC LYMPHOCITIC LEUKEMIA: ACHIEVEMENTS AND PERSPECTIVES
2019-04-04
6
INTERNATIONAL EXPERIENCE FOR THE USE OF ALEMTUZUMAB IN THERAPY OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
№12 3 2010
4
1
2
»